Open Account
Demo Account
About Us
Real-time Quotes & News
Market Analysis
Economic Calendar
Daily Market Analysis
Trading Platform
Platform Overview
How To Use
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
繁
简
EN
User Login
Open Account
Demo Account
繁
简
EN
User Login
Open Account
Demo Account
About Us
About Aspire
Features of Aspire
Real-time Quotes & News
Real-time Quotes
Real-time News
Market Analysis
Economic Calendar
Market Analysis
Trading Platform
Meta Trader 5
Platform Features
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
About Us
Terms
Metals Market
Trading Platform
Market Analysis
Promotion
FAQ
Contact
繁
简
EN
Real-time Quotes & News
Home
> Real-time Quotes & News
Real-time Quotes
Product
Bid
Ask
High
Low
Previous Close
{{ quote.symbol }}
{{ quote.bid }}
{{ quote.ask }}
High
{{ quote.high }}
Low
{{ quote.low }}
Previous Close
{{ quote.previousClose }}
*The above quotes are for reference only
Real-time News
2026-11-09
China A-share innovative-drug stocks rose intraday after choppy trading; Laimei Pharmaceutical jumped more than 15%, with Zhaoyan New Drug, Medicilon, Chengdu Xiandao, RemeGen and Nearshore Protein among the top gainers.
China A-share innovative-drug stocks rose intraday after choppy trading; Laimei Pharmaceutical jumped more than 15%, with Zhaoyan New Drug, Medicilon, Chengdu Xiandao, RemeGen and Nearshore Protein among the top gainers.
2026-11-09
A-share innovative drug concept stocks fluctuated higher during the session, with Lemei Pharmaceutical rising by more than 15%, and Zhaoyan New Drug, Medicilon, Chengdu Pioneer, Rongchang Bio and Nearshore Protein among the top gainers.
A-share innovative drug concept stocks fluctuated higher during the session, with Lemei Pharmaceutical rising by more than 15%, and Zhaoyan New Drug, Medicilon, Chengdu Pioneer, Rongchang Bio and Nearshore Protein among the top gainers.
2026-11-09
[Futures Hotspot Tracking] The supply of live pigs remains strong while demand is weak, and the average weight is rising, leading to an accumulation of inventory. The recovery from oversold conditions is met with the pressure of weak realities. Can t
[Futures Hotspot Tracking] The supply of live pigs remains strong while demand is weak, and the average weight is rising, leading to an accumulation of inventory. The recovery from oversold conditions is met with the pressure of weak realities. Can the main live pig contract reverse the downward trend?
2026-11-09
Hong Kong biotech stocks were firmer in early trade. Zai Lab (09688.HK) jumped over 12%, Akeso (09926.HK) rose ~7%, Ascentage Pharma (06855.HK) gained ~5%, Kangnuoya (02162.HK) added ~4%, BeiGene (06160.HK) was up just over 3%, and Rongchang Bio (099
Hong Kong biotech stocks were firmer in early trade. Zai Lab (09688.HK) jumped over 12%, Akeso (09926.HK) rose ~7%, Ascentage Pharma (06855.HK) gained ~5%, Kangnuoya (02162.HK) added ~4%, BeiGene (06160.HK) was up just over 3%, and Rongchang Bio (09995.HK) rose ~3%.
2026-11-09
Hong Kong-listed biotech stocks rose in early trading, with Zai Lab (09688.HK) surging over 12%, Akeso Biopharma (09926.HK) rising nearly 7%, Ascentage Pharma (06855.HK) gaining nearly 5%, ConocoPhillips (02162.HK) climbing nearly 4%, BeiGene (06160.
Hong Kong-listed biotech stocks rose in early trading, with Zai Lab (09688.HK) surging over 12%, Akeso Biopharma (09926.HK) rising nearly 7%, Ascentage Pharma (06855.HK) gaining nearly 5%, ConocoPhillips (02162.HK) climbing nearly 4%, BeiGene (06160.HK) climbing over 3%, and Rongchang Biotech (09995.HK) gaining nearly 3%.
2026-11-09
President Trump endorsed a bipartisan bill to speed federal permitting for major energy and infrastructure projects ahead of a Senate procedural vote Monday, urging senators to support legislation he said would codify an "America First" energy agenda
President Trump endorsed a bipartisan bill to speed federal permitting for major energy and infrastructure projects ahead of a Senate procedural vote Monday, urging senators to support legislation he said would codify an "America First" energy agenda and accelerate pipelines, mines and power-plant construction. Supporters say the measure would shorten approvals critical to grid modernization, AI data-center builds and some clean-energy projects; it has backing from oil companies and renewable developers. Passage faces obstacles: Congress has about two months left in the session, House Democratic leader Jeffries opposes the current text for lack of Democratic input, and progressive Democrats prefer to press for a stronger deal next year.
1
...
219
220
221
222
223
...
271
Real-time Quotes
Real-time News
Chat with us
, powered by
LiveChat